In pancreatic cancer, the inhibition of CXCL12 derived from carcinoma-associated fibroblasts could induce rapid T cell accumulation among cancer cells and play a synergistic role with anti-PD-L1 to kill cancer cells [28]. Here, CXCL12 is linked to carcinoma.